Fund Holdings — CAXTON CORP

Total Portfolio Value
$22.86M
Total Bought
$12.72M
Total Sold
$97.3K
Net Transaction
+$12.62M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
REZOLUTE INC(RZLT)1,603,9861,986,818+382,8327,15418,67681.70%+11,522
SPDR GOLD TR(GLD)4,9527,286+2,3341,5102,59011.33%+1,080
MIND MEDICINE MINDMED INC34,07327,011-7,0622213181.39%+97
COMPASS THERAPEUTICS INC(CMPX)43,46553,503+10,0381131870.82%+74
BICARA THERAPEUTICS INC10,94110,94101021730.76%+71
KYVERNA THERAPEUTICS INC(KYTX)22,98122,9810711380.60%+67
LEXEO THERAPEUTICS INC(LXEO)17,33217,3320701150.50%+45
SAB BIOTHERAPEUTICS INC(SABS)010,935+10,9350220.10%+22
BERKSHIRE HATHAWAY INC DEL632651+193073271.43%+20
CONTEXT THERAPEUTICS INC(CNTX)18,40318,403012180.08%+6
ENLIVEN THERAPEUTICS INC13,09713,09702632681.17%+5
INHIBIKASE THERAPEUTICS INC(IKT)16,39316,393032270.12%-5
Page 1 of 1
CAXTON CORP — 13F Holdings — Q3 2025 | TickerTrail